Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 9/2015

Inhalt (19 Artikel)

Original Article – Cancer Research

Association between co-inhibitory molecule gene tagging single nucleotide polymorphisms and the risk of colorectal cancer in Chinese

Jie Ge, Lin Zhu, Junde Zhou, Guangxiao Li, Ye Li, Shuying Li, Zhiwei Wu, Jiesheng Rong, Huiping Yuan, Yanhong Liu, Qiang Chi, Daxun Piao, Yashuang Zhao, Binbin Cui

Original Article – Cancer Research

Knockdown of telomeric repeat binding factor 2 enhances tumor radiosensitivity regardless of telomerase status

Xiaoxi Yang, Zheng Li, Lei Yang, Han Lei, Haijun Yu, Zhengkai Liao, Fuxiang Zhou, Conghua Xie, Yunfeng Zhou

Original Article – Cancer Research

In vitro and in vivo antitumor activity of a novel porphyrin-based photosensitizer for photodynamic therapy

Jing-Jing Chen, Ge Hong, Li-Jing Gao, Tian-Jun Liu, Wen-Jun Cao

Original Article – Cancer Research

Role of tumor cell surface lysosome-associated membrane protein-1 (LAMP1) and its associated carbohydrates in lung metastasis

Akhil Kumar Agarwal, Nithya Srinivasan, Rashmi Godbole, Shyam K. More, Srikanth Budnar, Rajiv P. Gude, Rajiv D. Kalraiya

Original Article – Cancer Research

The tubulysin analogue KEMTUB10 induces apoptosis in breast cancer cells via p53, Bim and Bcl-2

Oluwafunmilayo F. Lamidi, Monica Sani, Paolo Lazzari, Matteo Zanda, Ian N. Fleming

Open Access Original Article – Cancer Research

DNA methylation analysis of benign and atypical meningiomas: correlation between RUNX3 methylation and WHO grade

Aleksandra Majchrzak-Celińska, Jarosław Paluszczak, Marlena Szalata, Anna-Maria Barciszewska, Stanisław Nowak, Wanda Baer-Dubowska

Original Article – Cancer Research

Cullin1 is a novel prognostic marker and regulates the cell proliferation and metastasis in colorectal cancer

Weimin Wang, Yansu Chen, Jianliang Deng, Jianping Zhou, Xiancheng Gu, Yuehua Tang, Guoqiang Zhang, Yongfei Tan, Zhijun Ge, Yulin Huang, Shouyu Wang, Jianwei Zhou, Yan Zhou, Sujun Zhou

Original Article – Cancer Research

Down-regulation of ALDH1A3, CD44 or MDR1 sensitizes resistant cancer cells to FAK autophosphorylation inhibitor Y15

Vita Golubovskaya, Shalana O’Brien, Baotran Ho, Melissa Heffler, Jeffrey Conroy, Quang Hu, Dan Wang, Song Liu, William G. Cance

Review – Clinical Oncology

Clinical analysis of twenty cases of cervical cancer associated with pregnancy

Ting Xia, Yongliang Gao, Bin Wu, Yue Yang

Original Article – Clinical Oncology

A retrospective review of diagnosis and treatment modalities of neuroendocrine tumors (excluding primary lung cancer) in 10 oncological institutions of the East German Study Group of Hematology and Oncology (OSHO), 2010–2012

Georg Maschmeyer, Lars-Olof Mügge, Dietrich Kämpfe, Ute Kreibich, Stephan Wilhelm, Michael Aßmann, Maik Schwarz, Christoph Kahl, Susanne Köhler, Norbert Grobe, Dietger Niederwieser

Original Article – Clinical Oncology

AML versus ICU: outcome of septic AML patients in an intensive care setting

Christoph Sippel, Young Kim, Anja Wallau, Peter Brossart, Ingo Schmidt-Wolf, Peter Walger

Open Access Original Article – Clinical Oncology

A prognostic index model to predict the clinical outcomes for advanced pancreatic cancer patients following palliative chemotherapy

Peng Xue, Lifei Zhu, Zhiyong Wan, Weiyi Huang, Ning Li, Donghui Chen, Jiong Hu, Haiyan Yang, Liwei Wang

Original Article – Clinical Oncology

Efficacy of antifungal prophylaxis with oral suspension posaconazole during induction chemotherapy of acute myeloid leukemia

Karin G. Schrenk, Ulf Schnetzke, Katy Stegemann, Marie von Lilienfeld-Toal, Andreas Hochhaus, Sebastian Scholl

Original Article – Clinical Oncology

A multi-institutional study of clinicopathological features and molecular epidemiology of epidermal growth factor receptor mutations in lung cancer patients living with human immunodeficiency virus infection

Yusuke Okuma, Junko Tanuma, Hiroshi Kamiryo, Yuki Kojima, Mihoko Yotsumoto, Atsushi Ajisawa, Tomoko Uehira, Hirokazu Nagai, Yuichiro Takeda, Yasuhiro Setoguchi, Seiji Okada

Original Article – Clinical Oncology

Incidence, treatment, and outcome of parotid carcinoma, 1996–2011: a population-based study in Thuringia, Germany

Orlando Guntinas-Lichius, Thomas G. Wendt, Jens Buentzel, Dirk Esser, Daniel Böger, Andreas H. Mueller, Jörn-Uwe Piesold, Stefan Schultze-Mosgau, Peter Schlattmann, Harald Schmalenberg

Original Article – Clinical Oncology

Long-term follow-up of rituximab plus first-line mitoxantrone, chlorambucil, prednisolone and interferon-alpha as maintenance therapy in follicular lymphoma

Michael Herold, Christian W. Scholz, Frank Rothmann, Carsten Hirt, Volker Lakner, Ralph Naumann

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.